Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.266 USD | -5.07% | -7.73% | -46.86% |
03-26 | ISpecimen Inc. Announces the Board Changes | CI |
03-14 | Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024 |
Sales 2024 * | 11.54M 15.77M | Sales 2025 * | 12.7M 17.36M | Capitalization | 2.49M 3.4M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.4M | Net income 2025 * | -13M -17.77M | EV / Sales 2024 * | 0.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.2 x |
P/E ratio 2024 * |
-0.23
x | P/E ratio 2025 * |
-0.23
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.01% |
Latest transcript on iSpecimen Inc.
1 day | -5.07% | ||
1 week | -7.73% | ||
Current month | +14.66% | ||
1 month | +12.47% | ||
3 months | -46.77% | ||
6 months | -55.67% | ||
Current year | -46.86% |
Managers | Title | Age | Since |
---|---|---|---|
Tracy Curley
CEO | Chief Executive Officer | 62 | 20-07-31 |
Dawn Michelle
COO | Chief Operating Officer | - | 17-12-31 |
David Wages
CTO | Chief Tech/Sci/R&D Officer | - | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brooks
BRD | Director/Board Member | 73 | 21-06-15 |
Steve Gullans
BRD | Director/Board Member | 71 | 20-09-30 |
Andrew L. Ross
CHM | Chairman | 75 | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.266 | -5.07% | 186,456 |
24-04-25 | 0.2802 | +0.86% | 153,251 |
24-04-24 | 0.2778 | -5.86% | 313,896 |
24-04-23 | 0.2951 | -13.21% | 477,271 |
24-04-22 | 0.34 | +17.93% | 1,854,299 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.86% | 2.49M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.55B | |
+17.75% | 41.41B | |
+55.21% | 35.63B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- ISPC Stock